Karakter
Almelo, Overijssel, 7522, Netherlands
NCT Number: NCT06792227
The significant impact of eating disorders on adolescents necessitates the evaluation of current treatments. Family-based Treatment (FBT) is the standard treatment but has modest remission rates, highlighting the need for improvements. Assessing its effectiveness in adolescents with co-occurring mental health conditions is also crucial. In the Netherlands, there is a growing focus on home-based treatment. This study aims to enhance remission rates in FBT by adapting it for use in a home setting (FBT-H).
Interested in participating?
Request Info12 year–18 year
All sexes
Interventional
Not applicable
Almelo, Overijssel, 7522, Netherlands
Background:
The significant impact of eating disorders on adolescents necessitates the evaluation of current treatments. Family-based Treatment (FBT) is the standard treatment but has modest remission rates, highlighting the need for improvements. Assessing its effectiveness in adolescents with co-occurring mental health conditions is also crucial. In the Netherlands, there is a growing focus on home-based treatment. This study aims to enhance remission rates in FBT by adapting it for use in a home setting (FBT-H).
Objective:
This mixed-method study combines single case studies with qualitative research. The primary objective is to assess the effects and experiences of FBT-H in adolescents with eating disorders and co-occurring mental health conditions across variables such as weight, eating disorder symptoms, anxiety, mood, well-being, quality of life, and family dynamics. Additionally, it explores the experiences of adolescents, parents, and practitioners with FBT-H.
Methods:
Adolescents (12-18 years old) with anorexia nervosa (AN) or other specified feeding or eating disorders (OSFED), alongside co-occurring mental health conditions, will participate in FBT-H, attending about two home sessions per week for 6-12 months. Ten patients will be monitored with intensive measurements over one year. Baseline assessments include somatic screening, clinical interviews, and evaluations of mood, anxiety, and family dynamics. The primary outcome is weight change from baseline to one year post treatment, and secondary outcomes (e.g., eating disorder symptoms, quality of life, parent-child relationships, and caregiving burden) are assessed at baseline and then every three months. General well-being and therapeutic relationships are tracked weekly. One-year post treatment, somatic health, and mood/anxiety symptoms will be reassessed alongside qualitative interviews with adolescents, parents, and practitioners.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
FBT is a structured treatment lasting 6-12 months, typically in an outpatient setting, with weekly sessions that gradually decrease in frequency over time (Lock & Le Grange, 2015). It empowers parents to manage their child's recovery from the ED. The first phase focuses on weight restoration, with parents responsible for all eating decisions and restricting physical activity to reduce ED's influence. In the second phase, eating responsibility gradually shifts back to the adolescent. The final phase supports healthy adolescent development as ED symptoms subside.
The FBT-H adapts FBT to a home setting, with treatment led by family counselors and psychologists as part of a multidisciplinary team, including therapists, psychologists, a psychiatrist and a nurse specialist.
Time frame: Each session (week 1 - week 52, through study completion)
Weight - each session The weight of the adolescent in kilograms (kg) is measured weekly to monitor progress. The weight is measured by an FBT-H practitioner in an FBT-H session. The weight is measured in the same way every week (e.g., in underwear). This is a standard measurement associated with the FBT intervention and takes approximately 5 minutes.
Time frame: Each session (week 1 - week 52, through study completion)
The ORS is a questionnaire in which participants indicate how they are doing in four components of their lives: personal, interpersonal, social, and general (Miller et al., 2003); translated by Hafkenscheid et al., 2003). These four components form the four items in this questionnaire, which can be answered on a scale from 0-10. There is a child and adult version of the ORS. A score of more to the left (0) indicates a negative score on the corresponding component, and a score of more to the right (10) indicates a more positive one. The internal consistency, measured by Cronbach's alpha, is .97 (26). Adolescents and their parents participating in this study will be asked to fill out this questionnaire at the beginning of each session, which requires approximately 1 minute.
Time frame: Each session (week 1 - week 52, through study completion)
The SRS is a questionnaire in which adolescents express how they have experienced a session. The four items covered are relationship/contact, goals and topics, approach and method, and overall satisfaction. The SRS has the same setup as the previously mentioned ORS. The internal consistency, measured by Cronbach's alpha, is .88. Adolescents and parents participating in this study will be asked to fill out this questionnaire at the end of each treatment session, which takes approximately 1 minute.
Time frame: Adolescents in this study will complete the EDE-Q five times (T0 to T4)(T0 = Week 0, T1 = month 3, T2 = month 6, T3 = month 9, T4 = month 12) . It takes 10 minutes to complete the questionnaire.
The EDE-Q is a self-report questionnaire used to assess the behaviours and characteristics of ED. The EDE-Q consists of a global scale (22 items) and four subscales: restraint, eating concern, weight concern, and shape concern. Each question can be answered on a scale from 1 to 6 or with a yes/no response. Satisfactory levels of internal consistency were observed.
Time frame: Adolescents and their parents are asked to complete this questionnaire five times (T0 to T4)(T0 = Week 0, T1 = month 3, T2 = month 6, T3 = month 9, T4 = month 12) and it requires 10 minutes to complete.
Kidscreen-27 is a questionnaire measuring the quality of life of children in five dimensions: physical well-being, mental well-being, parent relations and autonomy, social support (from peers), and school situation. It consists of 27 questions, each of which has five answer options. Cronbach's alpha for all scales varies between average and good.
Time frame: The OKIV-R is administered a total of five times to both adolescents and their parents (T0 to T4)(T0 = Week 0, T1 = month 3, T2 = month 6, T3 = month 9, T4 = month 12) . The duration to complete the questionnaire is approximately10 minutes.
The OKIV-R consists of questionnaires that measure how parents view the relationship with their child and how children view the relationship with their parents. The child-mother, child-father, and parent-child versions are available. It has 21 statements, and each statement has five answer options varying from never (1) to always (5). The revised version of the OKIV (OKIV-R) has high internal consistency.
Time frame: The OBVL is administered a total of five times to parents participating in this study (T0 to T4)(T0 = Week 0, T1 = month 3, T2 = month 6, T3 = month 9, T4 = month 12) , and it requires 15 minutes of their time.
The OBVL is a questionnaire for parents about experiencing stress in parenting (Veerman et al., 2014).The OBVL consists of five scales (34 questions): parent-child relationship, parenting competence (7), depressive moods (7), role limitations (6), and health complaints (8). Each question has four answers that the parent can choose, varying from do not agree to totally agree. The scales of the OBVL have a reliability between .90 and .96 (McDonald's Omega).
Karakter Kinder- en Jeugdpsychiatrie
Other
Acronym: F-EET
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04174703
Anorexia Nervosa, Binge-Eating Disorder
Hamilton, Ontario, Canada
View Trial DetailsNCT07600671
Anorexia Nervosa, Binge Eating Disorder
Lebanon, New Hampshire, United States
View Trial DetailsNCT04127214
Anorexia Nervosa, Binge Eating
Argentona, Catalonia, Spain
View Trial DetailsNCT06345040
Anorexia Nervosa, Bulimia Nervosa
Hellerup, Copenhagen, Denmark
View Trial Details